Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Neurofibroma, Plexiform 1

Interventions

AZD 6244 4pirfenidone 2trametinib 1tipifarnib 1pomalidomide 1omipalisib 1cediranib 1abemaciclib 1Waiting Lists 1Vincristine 1Surveys and Questionnaires 1Specimen Handling 1Sorafenib 1Pharmacokinetics 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Carboplatin 1Biopsy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neurofibromatosis 1 × Pharmacokinetics × Clear all
NCT00727233 2019-12-12

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
9 enrolled
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡